相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Induced Chromosome Deletion in a Williams-Beuren Syndrome Mouse Model Causes Cardiovascular Abnormalities
Craig J. Goergen et al.
JOURNAL OF VASCULAR RESEARCH (2011)
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Grant R. Drummond et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
S. Wind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
MEDICAL PROGRESS Williams-Beuren Syndrome
Barbara R. Pober
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Apocynin decreases hydrogen peroxide and nirtate concentrations in exhaled breath in healthy subjects
J. Stefanska et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration
Christoph Kleinschnitz et al.
PLOS BIOLOGY (2010)
Induced chromosome deletions cause hypersociability and other features of Williams-Beuren syndrome in mice
Hong Hua Li et al.
EMBO MOLECULAR MEDICINE (2009)
Redox signaling, vascular function, and hypertension
Moo Yeol Lee et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Copy number variation at the 7q11.23 segmental duplications is a susceptibility factor for the Williams-Beuren syndrome deletion
Ivon Cusco et al.
GENOME RESEARCH (2008)
Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome
Barbara R. Pober et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Apocynin improves outcome in experimental stroke with a narrow dose range
X. N. Tang et al.
NEUROSCIENCE (2008)
Redox signaling in hypertension
Tamara M. Paravicini et al.
CARDIOVASCULAR RESEARCH (2006)
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
JP Habashi et al.
SCIENCE (2006)
Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension
M Del Campo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists
A Quan
EARLY HUMAN DEVELOPMENT (2006)
Activation of ETB receptors increases superoxide levels in sympathetic ganglia in vivo
YE Lau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Angiotensin II receptor antagonist treatment during pregnancy
S Alwan et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2005)
Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene
M Hultqvist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Multisystem study of 20 older adults with Williams syndrome
EM Cherniske et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Risk of sudden death in the Williams-Beuren syndrome
A Wessel et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Mutational mechanisms of Williams-Beuren syndrome deletions
M Bayés et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure - Role of xanthine-oxidase and extracellular superoxide dismutase
U Landmesser et al.
CIRCULATION (2002)
Cardiovascular manifestations in 75 patients with Williams syndrome
M Eronen et al.
JOURNAL OF MEDICAL GENETICS (2002)
Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney
T Chabrashvili et al.
HYPERTENSION (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Anomalies of the abdominal aorta in Williams-Beuren syndrome -: another cause of arterial hypertension
C Rose et al.
EUROPEAN JOURNAL OF PEDIATRICS (2001)
Exercise testing and 24-hour ambulatory blood pressure monitoring in children with Williams syndrome
U Giordano et al.
PEDIATRIC CARDIOLOGY (2001)
Mouse models of genetic diseases resulting from mutations in elastic fiber proteins
HC Dietz et al.
MATRIX BIOLOGY (2000)
A physical map, including a BAC/PAC clone contig, of the Williams-Beuren syndrome-deletion region at 7q11.23
R Peoples et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
